HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Höchtl Selected Research

Amidox

10/2004Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Höchtl Research Topics

Disease

3Acute Coronary Syndrome
01/2014 - 08/2010
3Hemorrhage
01/2014 - 08/2010
2Thrombosis (Thrombus)
01/2014 - 06/2012
2ST Elevation Myocardial Infarction
01/2014 - 08/2010
1Atrial Fibrillation
06/2013
1Coronary Artery Disease (Coronary Atherosclerosis)
08/2010
1Neoplasms (Cancer)
10/2004
1Leukemia
10/2004

Drug/Important Bio-Agent (IBA)

3Prasugrel HydrochlorideFDA Link
01/2014 - 08/2010
2Clopidogrel (Plavix)FDA Link
06/2012 - 08/2010
1Adenosine Diphosphate (ADP)IBA
01/2014
1P-SelectinIBA
06/2013
1AntigensIBA
06/2013
1TicagrelorIBA
06/2012
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2012
1Heparin (Liquaemin)FDA LinkGeneric
08/2010
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2010
1Enoxaparin (Lovenox)FDA LinkGeneric
08/2010
1AmidoxIBA
10/2004
1Cytarabine (Cytosar-U)FDA LinkGeneric
10/2004
1Antineoplastic Agents (Antineoplastics)IBA
10/2004
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
10/2004

Therapy/Procedure

3Therapeutics
01/2014 - 08/2010
2Stents
01/2014 - 06/2012
1Percutaneous Coronary Intervention
06/2012
1Thrombolytic Therapy
08/2010
1Secondary Prevention
08/2010
1Drug Therapy (Chemotherapy)
10/2004